Stock listing
1779 Stock Price, News, Filings & Events — Longbio Pharma (suzhou) Co., Ltd. Class H
Selected listing: 1779 · HKEX · HKD · HK
This page tracks Longbio Pharma (suzhou) Co., Ltd. Class H's 1779:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 1779:HKEX. 1779:HKEX is the stock-level entry point for investors researching Longbio Pharma (suzhou) Co., Ltd. Class H, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Longbio Pharma (Suzhou) Co., Ltd. Class H, trading under the ticker 1779 on the Hong Kong market, has a market capitalization of approximately HKD 876.77 million. The company focuses on the development and commercialization of innovative pharmaceutical products. Longbio Pharma aims to address unmet medical needs through its research and development efforts.
- Ticker
- 1779:HKEX
- Asset type
- Stock
- Market cap
- $1.03B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
Longbio Pharma (suzhou) Co., Ltd. Class H 1779:HKEX stock context
This page tracks Longbio Pharma (suzhou) Co., Ltd. Class H's 1779:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 1779:HKEX. 1779:HKEX is the stock-level entry point for investors researching Longbio Pharma (suzhou) Co., Ltd. Class H, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Longbio Pharma (Suzhou) Co., Ltd. Class H, trading under the ticker 1779 on the Hong Kong market, has a market capitalization of approximately HKD 876.77 million. The company focuses on the development and commercialization of innovative pharmaceutical products. Longbio Pharma aims to address unmet medical needs through its research and development efforts.
Latest news from Longbio Pharma (suzhou) Co., Ltd. Class H
Research Longbio Pharma (suzhou) Co., Ltd. Class H
Longbio Pharma (suzhou) Co., Ltd. Class H investor report
Review AI stock analysis and investor report context for 1779:HKEX.
Longbio Pharma (suzhou) Co., Ltd. Class H company profile
View the public company page for Longbio Pharma (suzhou) Co., Ltd. Class H on 6ix.
Longbio Pharma (suzhou) Co., Ltd. Class H news
Read company news and market updates connected to Longbio Pharma (suzhou) Co., Ltd. Class H.
Longbio Pharma (suzhou) Co., Ltd. Class H investor events
Find investor webinars, events, and replay context for Longbio Pharma (suzhou) Co., Ltd. Class H.